ANALYZING THE IMPACT OF DRUG RELATED INCIDENTS ON HEALTHCARE SYSTEMS AND POLICY: A SYSTEMATIC REVIEW OF INCIDENTS AND TRAGEDIES CAUSED BY DRUG-RELATED EVENTS AND THEIR IMPACT ON HEALTHCARE POLICY, REGULATION, AND PRACTICE

Pharmaceutical Management

Drug-related incidents refer to any events that occur due to the use of contaminated, adulterated, spurious or defective drugs as well as events occurring due to medication errors and adverse drug effects. Such issues are rising globally at exponential pace. These incidents are resulting in side effects Due to the presence of a suspected cancer-causing contaminant, the US Food and Drug Administration (FDA) recalled numerous blood pressure drugs in 2018. Ranitidine, a drug used to treat heartburn, was recalled in 2019 because it may contain a human carcinogen. Due to the presence of methanol, which can be hazardous when consumed or absorbed via the skin, hand sanitizers were recalled in 2020.Contamination-related drug recalls can greatly impact the pharma industry and the general health of the public. Drug recalls can potentially damage people and generate financial losses for drug producers and distributors. Drug recalls can occasionally result in a scarcity of life-saving medications. Public health and safety are seriously at risk when drugs are recalled owing to contamination. Numerous medicine recalls resulting from contamination have recently been brought to light, along with their possible effects on patients and the pharmaceutical business. Developing countries like India has faced lots of issues with the quality of medicine drawing eyeballs from nations across the world. Working cooperatively to avoid and handle contamination-related drug recalls is crucial for regulatory authorities, drug producers, and healthcare providers.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.